Notably, the majority of clock modulators showed a considerable binding affinity for mental disorder drug targets, with consistently lower BE (Range: 5.4 to −11.7 kcal/mol) compared to the positive control VPA-PPARα interaction (−9.04 kcal/mol). The gene discussed is CLOCK; the disease is psychiatric disorder.